Paid Clinical Trials for Blood Disorders, Hemophilia

Paid Clinical Trials and Focus Groups by Category

All Categories ... Medical Conditions » ... Blood Disorders » ... Hemophilia

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

Conditions: Hemophilia A; Hemophilia B; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D and calcium
Sponsors: Virginia Commonwealth University; CSL Behring
Recruiting - verified March 2010
Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Condition: Severe Hemophilia A
Interventions: Drug: FVIII Concentrates; Drug: FVIII/VWF concentrates
Sponsors: City of Hope Medical Center; Grifols Biologicals Inc.; CSL Behring; Talecris Biotherapeutics; Biotest Pharmaceuticals Corporation
Recruiting - verified March 2010
Trial to Evaluate the Efficacy and Safety of a New Formulation of Kogenate for Hemophilia A

Conditions: Blood Coagulation Disorders; Hemophilia A
Interventions: Biological: Recombinant Factor VIII (Kogenate PF, BAY81-8973); Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222); Biological: Recombinant Factor VIII (Kogenate PF, BAY81-8973); Biological: Recombinant Factor VIII (Kogenate PF, BAY81-8973)
Sponsor: Bayer
Recruiting - verified March 2010
Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543 and NN7008-3545

Condition: Haemophilia A
Interventions: Drug: recombinant factor VIII (N8); Drug: recombinant factor VIII (N8)
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B

Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
Sponsors: St. Jude Children's Research Hospital; Stanford University; Katharine Dormandy Haemophilia Centre and Haemostasis Unit
Recruiting - verified March 2010
Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

Condition: Haemophilia A or B With Inhibitors
Interventions: Drug: activated recombinant human factor VII, long acting; Drug: activated recombinant human factor VII, long acting; Drug: activated recombinant human factor VII, long acting
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Safety and Efficacy of N8 in Haemophilia A Subjects

Condition: Haemophilia A
Interventions: Drug: recombinant factor VIII (N8); Procedure: Blood drawn for laboratory testing
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

Conditions: Hematologic Disease; Blood Coagulation Disorders
Interventions: Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222); Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222); Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222)
Sponsor: Bayer
Recruiting - verified March 2010
Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment. (SPINART)

Condition: Hemophilia A
Interventions: Drug: Recombinant Anti-hemophilic Factor VIII (Kogenate®FS); Drug: Recombinant Anti-hemophilic Factor VIII (Kogenate®FS)
Sponsor: Bayer
Recruiting - verified March 2010
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Condition: Severe Hemophilia A
Intervention: Drug: Alphanate SD/HT
Sponsor: Grifols Biologicals Inc.
Recruiting - verified March 2010

Paid Clinical Trials for Blood Disorders, Hemophilia - Clinical Trials

Paid Clinical Trials for Blood Disorders, Hemophilia

Paid Clinical Trials and Focus Groups by Category

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials